(HBC1) HSBC Holdings - Ratings and Ratios
Retail Banking, Wealth Management, Commercial Banking, Investment Services
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 4.80% |
| Yield on Cost 5y | 20.26% |
| Yield CAGR 5y | 35.12% |
| Payout Consistency | 94.1% |
| Payout Ratio | 66.3% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 23.2% |
| Value at Risk 5%th | 35.3% |
| Relative Tail Risk | -7.63% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.58 |
| Alpha | 41.65 |
| CAGR/Max DD | 1.36 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.482 |
| Beta | 0.298 |
| Beta Downside | 0.617 |
| Drawdowns 3y | |
|---|---|
| Max DD | 26.10% |
| Mean DD | 3.88% |
| Median DD | 2.73% |
Description: HBC1 HSBC Holdings December 01, 2025
HSBC Holdings plc (XETRA:HBC1) is a globally diversified bank that operates through three core segments: Wealth and Personal Banking, Commercial Banking, and Global Banking and Markets. The Wealth and Personal Banking arm delivers retail and high-net-worth services such as deposits, mortgages, credit cards, and wealth-management products. Commercial Banking focuses on credit, treasury, payments, trade finance, and capital-raising for SMEs to large corporates. Global Banking and Markets provides financing, advisory, and a full suite of market-risk products (FX, rates, equities, money markets) to governments, institutions, and private investors.
Key performance indicators that investors watch include HSBC’s CET1 capital ratio (currently around 15.5 %), net interest margin (NIM) of roughly 1.6 % in Q3 2024, and loan-to-deposit growth of 3.2 % year-over-year, driven largely by expanding Asian markets where the bank holds a 40 % share of corporate banking assets. The bank’s earnings are sensitive to global interest-rate cycles, sovereign-bond yields, and cross-border trade volumes, making macro-economic trends in the U.S., Europe, and especially China pivotal to its revenue outlook.
For a deeper, data-driven look at how these drivers translate into valuation metrics, you might explore HSBC’s profile on ValueRay to see the latest analyst consensus and scenario analysis.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income (17.69b TTM) > 0 and > 6% of Revenue (6% = 6.60b TTM) |
| FCFTA 0.02 (>2.0%) and ΔFCFTA 0.76pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -1443 % (prev -2390 %; Δ 946.7pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.02 (>3.0%) and CFO 65.31b > Net Income 17.69b (YES >=105%, WARN >=100%) |
| Net Debt (-113.65b) to EBITDA (41.73b) ratio: -2.72 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.15 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (17.30b) change vs 12m ago -4.70% (target <= -2.0% for YES) |
| Gross Margin 40.42% (prev 34.23%; Δ 6.18pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 3.48% (prev 2.13%; Δ 1.35pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 0.07 (EBITDA TTM 41.73b / Interest Expense TTM 65.59b) >= 6 (WARN >= 3) |
Altman Z'' -3.00
| (A) -0.49 = (Total Current Assets 284.51b - Total Current Liabilities 1873.09b) / Total Assets 3234.22b |
| (B) 0.05 = Retained Earnings (Balance) 152.40b / Total Assets 3234.22b |
| (C) 0.00 = EBIT TTM 4.37b / Avg Total Assets 3166.42b |
| (D) 0.06 = Book Value of Equity 170.16b / Total Liabilities 3035.53b |
| Total Rating: -3.00 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 63.84
| 1. Piotroski 4.0pt |
| 2. FCF Yield 31.29% |
| 3. FCF Margin 55.79% |
| 4. Debt/Equity 0.91 |
| 5. Debt/Ebitda -2.72 |
| 6. ROIC - WACC (= -5.99)% |
| 7. RoE 9.31% |
| 8. Rev. Trend 45.57% |
| 9. EPS Trend 20.44% |
What is the price of HBC1 shares?
Over the past week, the price has changed by +0.90%, over one month by +10.33%, over three months by +13.14% and over the past year by +49.80%.
Is HBC1 a buy, sell or hold?
What are the forecasts/targets for the HBC1 price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 16.8 | 25% |
HBC1 Fundamental Data Overview December 21, 2025
Market Cap USD = 269.71b (228.99b EUR * 1.1778 EUR.USD)
P/E Trailing = 16.4691
P/E Forward = 9.9701
P/S = 3.9498
P/B = 1.3414
P/EG = 2.3191
Beta = 0.394
Revenue TTM = 110.08b USD
EBIT TTM = 4.37b USD
EBITDA TTM = 41.73b USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = 173.43b USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = -113.65b USD (from netDebt column, last fiscal year)
Enterprise Value = 196.31b USD (269.71b + Debt 173.43b - CCE 246.82b)
Interest Coverage Ratio = 0.07 (Ebit TTM 4.37b / Interest Expense TTM 65.59b)
FCF Yield = 31.29% (FCF TTM 61.42b / Enterprise Value 196.31b)
FCF Margin = 55.79% (FCF TTM 61.42b / Revenue TTM 110.08b)
Net Margin = 16.07% (Net Income TTM 17.69b / Revenue TTM 110.08b)
Gross Margin = 40.42% ((Revenue TTM 110.08b - Cost of Revenue TTM 65.59b) / Revenue TTM)
Gross Margin QoQ = 53.46% (prev 52.34%)
Tobins Q-Ratio = 0.06 (Enterprise Value 196.31b / Total Assets 3234.22b)
Interest Expense / Debt = 8.99% (Interest Expense 15.58b / Debt 173.43b)
Taxrate = 24.56% (1.79b / 7.29b)
NOPAT = 3.30b (EBIT 4.37b * (1 - 24.56%))
Current Ratio = 0.15 (Total Current Assets 284.51b / Total Current Liabilities 1873.09b)
Debt / Equity = 0.91 (Debt 173.43b / totalStockholderEquity, last quarter 191.43b)
Debt / EBITDA = -2.72 (Net Debt -113.65b / EBITDA 41.73b)
Debt / FCF = -1.85 (Net Debt -113.65b / FCF TTM 61.42b)
Total Stockholder Equity = 189.94b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.55% (Net Income 17.69b / Total Assets 3234.22b)
RoE = 9.31% (Net Income TTM 17.69b / Total Stockholder Equity 189.94b)
RoCE = 0.32% (EBIT 4.37b / Capital Employed (Total Assets 3234.22b - Current Liab 1873.09b))
RoIC = 0.99% (NOPAT 3.30b / Invested Capital 331.91b)
WACC = 6.98% (E(269.71b)/V(443.13b) * Re(7.11%) + D(173.43b)/V(443.13b) * Rd(8.99%) * (1-Tc(0.25)))
Discount Rate = 7.11% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -33.33 | Cagr: -4.90%
[DCF Debug] Terminal Value 81.43% ; FCFE base≈51.02b ; Y1≈62.94b ; Y5≈107.38b
Fair Price DCF = 106.4 (DCF Value 1826.38b / Shares Outstanding 17.17b; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 20.44 | EPS CAGR: 35.58% | SUE: N/A | # QB: 0
Revenue Correlation: 45.57 | Revenue CAGR: 22.62% | SUE: N/A | # QB: 0